Our blog provides updates on Absolute Antibody’s technologies, products and services. Browse the latest posts to learn about company developments and events.

Supporting Cancer Immunotherapy Research: Recombinant, Syngeneic Antibodies Against Mouse PD-1

An Introduction to Absolute Antibody Custom Services

Submit Your VivopureX™ Research Proposal to Earn a Research Microgrant from Absolute Antibody

Science Showcase: All About the Antibodies

Engineering Antibody Reagents to Facilitate In Vivo Research

Comparing potential bispecific formats of trastuzumab and a humanized OKT3

Converting a Popular Puromycin Antibody to Recombinant Production

Antibody Humanization for Infectious Disease Serological Assay Development

Supporting Alzheimer’s Research: Recombinant Antibodies Against Amyloid Beta

Recombinant Antibodies Against Influenza A Virus Subtype H5N1

Engineered Mouse-Ly-6G Antibody Shows Near Complete Neutrophil Depletion In Vivo

Recombinant Engineered Human Cytomegalovirus Antibodies

Respiratory Syncytial Virus (RSV) Antibodies

Comparing potential bispecific formats comprising of trastuzumab and a humanized OKT3

Improving In Vivo Research with Recombinant Mouse Antibodies and Isotype Controls

Prevent catastrophic loss of your hybridoma through antibody sequencing

Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide

Recombinant Engineered Anti-Norovirus Antibodies

Using Antibody Sequencing to Save a Contaminated Hybridoma for Recombinant Expression

Why Your Hybridoma Should be Sequenced with NGS Instead of PCR

Recombinant Antibodies Against Nipah Virus

Collaborating with the University of Sheffield to Increase Antibody Expression Yields

Absolute Antibody Increases Automation Capabilities and Expands Production Facility

Spotlight On: Z-DNA Antibodies

Engineering ACE2 Fc Fusion Proteins For COVID-19 Prophylaxis

Monkeypox Virus Antibodies for Research and Diagnostics

Absolute Antibody Expands Prometheus™ Antibody Humanization Service to Include Non-Murine Origin Species

PD-1 Fc Silent™ Antibody Improves Anti-Tumor Activity in Mice

Absolute Antibody Licenses Novel Fc Silencing Technology from mAbsolve

Absolute Antibody Wins Made in the North East Award